{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T21:47:15Z","timestamp":1773092835341,"version":"3.50.1"},"reference-count":16,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A 59-year-old female with Child-Pugh class B cirrhosis attributed to nonalcoholic steatohepatitis complicated by hepatic encephalopathy, portal hypertension with esophageal varices, and thrombocytopenia is seen for management of an acute segmental right lower lobe pulmonary embolism in a clinic. She is hemodynamically stable. Complete blood count is notable for hemoglobin 11.6\u200a\u2009g\/dL and platelets 80 K\/\u03bcL. Prothrombin time is 12.6 seconds; partial thromboplastin time, 33.7 seconds; and fibrinogen, 221\u200a\u2009mg\/dL. She was referred to discuss if a direct oral anticoagulant (DOAC) can be used for anticoagulation. What would you suggest?<\/jats:p>","DOI":"10.1182\/hematology.2023000514","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T15:09:40Z","timestamp":1702048180000},"page":"289-293","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Direct oral anticoagulants to treat deep venous thrombosis and pulmonary embolism in patients with cirrhosis: are we there yet?"],"prefix":"10.1182","volume":"2023","author":[{"given":"Amber","family":"Afzal","sequence":"first","affiliation":[{"name":"1 Division of Hematology, Department of Medicine, Washington University, St Louis, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Schaefer","sequence":"additional","affiliation":[{"name":"2 Division of Hematology\/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2023,12,8]]},"reference":[{"issue":"9","key":"2024010216471920800_hem2023000514C1","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.cgh.2010.05.014","article-title":"Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study","volume":"8","author":"Wu","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"2024010216471920800_hem2023000514C2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.31264","article-title":"Mortality and hepatic decompensation in patients with cirrhosis and atrial fibrillation treated with anticoagulation","volume":"73","author":"Serper","year":"2021","journal-title":"Hepatology"},{"issue":"9","key":"2024010216471920800_hem2023000514C3","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/liv.14992","article-title":"Safety of direct oral anticoagulants in patients with advanced liver disease","volume":"41","author":"Semmler","year":"2021","journal-title":"Liver Int"},{"issue":"2","key":"2024010216471920800_hem2023000514C4","doi-asserted-by":"crossref","first-page":"e88390","DOI":"10.1371\/journal.pone.0088390","article-title":"Differential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosis","volume":"9","author":"Potze","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"2024010216471920800_hem2023000514C5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/bcp.12054","article-title":"Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct factor Xa inhibitor: rivaroxaban pharmacokinetics and pharmacodynamics in hepatic impairment","volume":"76","author":"Kubitza","year":"2013","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2024010216471920800_hem2023000514C6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.dld.2021.07.039","article-title":"Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: a systematic review and meta-analysis","volume":"54","author":"Koh","year":"2022","journal-title":"Dig Liver Dis"},{"issue":"Supplement 1","key":"2024010216471920800_hem2023000514C7","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1182\/blood-2022-168446","article-title":"Preliminary result of a pilot study of apixaban in the treatment of splanchnic vein thrombosis","volume":"140","author":"Kim","year":"2022","journal-title":"Blood"},{"issue":"4","key":"2024010216471920800_hem2023000514C8","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/ehjcvp\/pvab032","article-title":"Anticoagulation in atrial fibrillation and liver disease: a pooled-analysis of &gt;20 000 patients","volume":"8","author":"Chen","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"4","key":"2024010216471920800_hem2023000514C9","first-page":"e24029","article-title":"Drug use evaluation of direct oral anticoagulants (DOACs) in patients with advanced cirrhosis","volume":"14","author":"Jarboe L","year":"2022","journal-title":"Cureus"},{"key":"2024010216471920800_hem2023000514C10","article-title":"Modest performance of available risk prediction models when used to predict hemorrhage in patients with chronic liver disease","author":"Afzal","year":"2022","journal-title":"ISTH Congress"},{"issue":"1s suppl 1","key":"2024010216471920800_hem2023000514C11","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1097\/MEG.0000000000002035","article-title":"Major gastrointestinal bleeding risk with direct oral anticoagulants: does type and dose matter? - a systematic review and network meta-analysis","volume":"33","author":"Radadiya","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"2024010216471920800_hem2023000514C12","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s10620-015-4012-2","article-title":"Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation","volume":"61","author":"Intagliata","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"4","key":"2024010216471920800_hem2023000514C13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/ejh.12844","article-title":"The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis","volume":"98","author":"Hum","year":"2017","journal-title":"Eur J Haematol"},{"issue":"10","key":"2024010216471920800_hem2023000514C14","first-page":"479","article-title":"Retrospective review on the safety and efficacy of direct oral anticoagulants compared with warfarin in patients with cirrhosis","volume":"37","author":"Jones","year":"2020","journal-title":"Fed Pract"},{"issue":"1563","key":"2024010216471920800_hem2023000514C15","first-page":"52","article-title":"Bleeding risk of oral anticoagulants in liver cirrhosis","volume":"135","author":"Munevar Aquite","year":"2022","journal-title":"N Z Med J"},{"issue":"7","key":"2024010216471920800_hem2023000514C16","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1177\/10600280211047433","article-title":"Safety and efficacy of direct oral anticoagulants in patients with moderate to severe cirrhosis","volume":"56","author":"Oldham","year":"2022","journal-title":"Ann Pharmacother"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2023\/1\/289\/2178819\/289afzal.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2023\/1\/289\/2178819\/289afzal.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T16:47:53Z","timestamp":1704214073000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2023\/1\/289\/506427\/Direct-oral-anticoagulants-to-treat-deep-venous"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,8]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,8]]},"published-print":{"date-parts":[[2023,12,8]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2023000514","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12,8]]},"published":{"date-parts":[[2023,12,8]]}}}